SCHEMBL1631531

SCHEMBL1631531

COc1cc(OC)c(-c2ccnn2-c2ccccc2F)cc1I

nearest known ligand 0.62

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
▸ HSP90AA1 P07900 1/20 0.62
▸ PDE10A Q9Y233 4/20 0.44
▸ KCNN4 O15554 5/20 0.41
▸ SMN1; SMN2 Q16637 1/20 0.40
▸ NR3C2 P08235 2/20 0.40
▸ MAPK14 Q16539 1/20 0.39
▸ FLT3 P36888 1/20 0.37
▸ SLC2A1 P11166 1/20 0.35
▸ SLC2A2 P11168 1/20 0.35
▸ SLC2A3 P11169 1/20 0.35
▸ PTGS2 P35354 1/20 0.33
▸ HTR1A P08908 1/20 0.33
▸ HTR7 P34969 1/20 0.33
▸ HTR2B P41595 1/20 0.33
▸ SMO Q99835 1/20 0.33
▸ ALK Q9UM73 1/20 0.33
▸ MAPT P10636 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1219068 0.86 HSP90AA1 (0.45) HSP90AA1PDE10ANR3C2MAPK14FLT3
SCHEMBL1629564 0.85 HSP90AA1 (0.44) HSP90AA1PDE10AKCNN4NR3C2MAPK14
SCHEMBL1630525 0.84 HSP90AA1 (0.44) HSP90AA1PDE10ANR3C2HTR2B
SCHEMBL1629555 0.82 PDE10A (0.48) HSP90AA1PDE10AALKMAPT
SCHEMBL626539 0.82 KCNN4 (0.55) HSP90AA1PDE10AKCNN4SMN1; SMN2NR3C2
SCHEMBL1631623 0.81 P2RX7 (0.42) HSP90AA1KCNN4NR3C2MAPT
SCHEMBL1630306 0.81 ALDH1A1 (0.41) HSP90AA1SMN1; SMN2NR3C2MAPT
SCHEMBL1631575 0.80 HSP90AA1 (0.40) HSP90AA1NR3C2ALKMAPT
SCHEMBL1630405 0.80 HSP90AA1 (0.45) HSP90AA1PDE10AKCNN4SMN1; SMN2NR3C2
SCHEMBL1629937 0.80 HSP90AA1 (0.45) HSP90AA1PDE10AKCNN4SMN1; SMN2NR3C2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1776346-B1 1,5-Diphenylpyrazoles MERCK PATENT GMBH (DE) 2013-06-26 — — EP disclosed
US-7932401-B2 Heat Shock Protein 90 (HSP90) inhibitors; 5-(2-hydroxy-4-methoxyphenyl)-1-(3-nitrophenyl)-1H-pyrazole for example; antitumor agent, viral diseases, transplant rejection, cystic fibrosis, angiogenesis inhibition, infectious, autoimmune, or inflammatory diseases, ischemia, chemotherapy cytoprotectant MERCK PATENT GMBH (DE) 2011-04-26 — — US disclosed
US-20080085904-A1 1,5-Diphenylpyrazoles MERCK PATENT GMBH (DE) 2008-04-10 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080085904-A1 1,5-Diphenylpyrazoles HSP90AB1, HSP90AA1, HSP90AB2P HSP90AA1 2/4885PDE10A 3756/4885KCNN4 4736/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback